5 Best Pharma Stocks to Invest In Now

4. Bristol-Myers Squibb Company (NYSE:BMY)

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best pharma stocks to invest in now. Bristol-Myers Squibb Company (NYSE:BMY) announced on March 29 positive data from the Phase 3 SCOUT-HCM trial of Camzyos, which marks the first study of a cardiac myosin inhibitor (CMI) in adolescents aged 12 years to <18 years with symptomatic obstructive hypertrophic cardiomyopathy. The company reported that the SCOUT-HCM trial met its primary endpoint, exhibiting a clinically meaningful and statistically significant reduction from baseline in Valsalva left ventricular outflow tract gradient at Week 28 with Camzyos compared to placebo.

Bristol-Myers Squibb Company (NYSE:BMY) also reported that Camzyos demonstrated meaningful improvement over placebo in multiple secondary endpoints at 28 weeks, adding that similar safety findings were observed in the Camzyos and placebo groups. Management stated that the data is being presented as a late-breaking clinical trial presentation at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo 2026, with simultaneous publication in The New England Journal of Medicine.

Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced medicines for serious diseases. Its medicines fall into various therapeutic classes, including hematology, oncology, cardiovascular, immunology, and neuroscience.